Latent membrane protein 1 mediates the resistance of nasopharyngeal carcinoma cells to TRAIL-induced apoptosis by activation of the PI3K/Akt signaling pathway
- PMID: 21850380
- DOI: 10.3892/or.2011.1423
Latent membrane protein 1 mediates the resistance of nasopharyngeal carcinoma cells to TRAIL-induced apoptosis by activation of the PI3K/Akt signaling pathway
Abstract
The 5-year survival rate of nasopharyngeal carcinoma (NPC) is still disappointing despite the much improved technologies in its treatment. Tumor necrosis factor-related apoptosis inducing ligand (TRAIL) can selectively induce apoptosis in most tumor cells while sparing normal cells. However, its potential in the treatment of NPC has been limited by the eventual emergence of drug resistance. Latent membrane protein 1 (LMP1) is a major oncogene of the human DNA tumor virus Epstein-Barr virus (EBV) and is associated with the development of NPC and the emergence of chemo-resistance in NPC. In this study, we investigated the potential role of LMP1 in TRAIL resistance in CNE-1 NPC cells. Results show that overexpression of LMP1 could induce TRAIL resistance in NPC cells without influencing death receptors. The LMP1-induced TRAIL resistance is associated with increased expression of FLIP and elevated cleavage of caspase-8 without altering the TRAIL-mediated mitochondrial events and Bid cleavage. Knockdown of the FLIP gene with siRNA prevented the LMP1-induced TRAIL resistance. Furthermore, we found that overexpression of LMP1 activated Akt. Inhibition of Akt with LY294002 completely prevented the LMP1-induced FLIP expression and TRAIL resistance. Together, these results show that LMP1 can inhibit the TRAIL-mediated apoptosis through activation of PI3K/Akt and expression of FLIP in CNE-1 NPC cells, and may provide new methods to prevent and reverse drug resistance in NPC.
Similar articles
-
[Inhibition of PI3K-Akt pathway reverses LMP1 induced TRAIL resistance in nasopharyngeal carcinoma cell].Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2016 May 5;30(9):744-747. doi: 10.13201/j.issn.1001-1781.2016.09.019. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2016. PMID: 29771028 Chinese.
-
Simultaneously targeting bcl-2 and Akt pathways sensitizes nasopharyngeal carcinoma to tumor necrosis factor-related apoptosis-inducing ligand.Cancer Biother Radiopharm. 2012 Feb;27(1):88-95. doi: 10.1089/cbr.2011.1031. Epub 2011 Sep 21. Cancer Biother Radiopharm. 2012. PMID: 21936689
-
Simultaneously targeting Bcl-2 and Akt pathways reverses resistance of nasopharyngeal carcinoma to TRAIL synergistically.Tumori. 2011 Nov-Dec;97(6):762-70. doi: 10.1177/030089161109700614. Tumori. 2011. PMID: 22322844
-
Modulation of the tumor microenvironment by Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma.Cancer Sci. 2018 Feb;109(2):272-278. doi: 10.1111/cas.13473. Epub 2018 Jan 21. Cancer Sci. 2018. PMID: 29247573 Free PMC article. Review.
-
The Role of LMP1 in Epstein-Barr Virus-associated Gastric Cancer.Curr Cancer Drug Targets. 2024;24(2):127-141. doi: 10.2174/1568009623666230512153741. Curr Cancer Drug Targets. 2024. PMID: 37183458 Review.
Cited by
-
Roles of the PI3K/Akt pathway in Epstein-Barr virus-induced cancers and therapeutic implications.World J Virol. 2012 Dec 12;1(6):154-61. doi: 10.5501/wjv.v1.i6.154. World J Virol. 2012. PMID: 24175221 Free PMC article. Review.
-
Targeting the signaling in Epstein-Barr virus-associated diseases: mechanism, regulation, and clinical study.Signal Transduct Target Ther. 2021 Jan 12;6(1):15. doi: 10.1038/s41392-020-00376-4. Signal Transduct Target Ther. 2021. PMID: 33436584 Free PMC article. Review.
-
Embelin prevents LMP1-induced TRAIL resistance via inhibition of XIAP in nasopharyngeal carcinoma cells.Oncol Lett. 2016 Jun;11(6):4167-4176. doi: 10.3892/ol.2016.4522. Epub 2016 May 5. Oncol Lett. 2016. PMID: 27313761 Free PMC article.
-
F-box proteins involved in cancer-associated drug resistance.Oncol Lett. 2018 Jun;15(6):8891-8900. doi: 10.3892/ol.2018.8500. Epub 2018 Apr 16. Oncol Lett. 2018. PMID: 29805625 Free PMC article. Review.
-
Hsp90 up-regulates PD-L1 to promote HPV-positive cervical cancer via HER2/PI3K/AKT pathway.Mol Med. 2021 Oct 19;27(1):130. doi: 10.1186/s10020-021-00384-2. Mol Med. 2021. PMID: 34666670 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous